Skip to main content

Table 3 Survey Responses on Hydroxychloroquine Dosage and Guidelines (Post-intervention)

From: The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institution

Reasons Rheumatologists, n (%)
(total = 16)
Dermatologists, n (%)
(total = 12)
Total, n (%)
(total = 28)
Chose incorrect weight-based dose 0 (0) 3 (25.0) 3 (10.7)
Chose ideal body weight rather than actual weight 4 (25.0) 5 (41.7) 9 (32.1)
Report not using the guidelines 3 (18.8) 2 (16.7) 5 (17.9)
Express concern for non-adherence if changing the dose 3 (18.8) 2 (16.7) 5 (17.9)
Express concern for disease flare if changing the dose 7 (43.8) 4 (33.3) 11 (39.3)
Report being unaware of the CDS tool 5 (31.3) 5 (41.7) 10 (35.7)
Agree with the guidelines 11 (68.8 10 (83.3) 21 (75.0)
Report the CDS tool changed their practice 4 (25.0) 3 (25.0) 7 (25.0)
Report the CDS tool is helpful/beneficial 8 (50.0) 3 (25.0) 13 (46.4)